177 related articles for article (PubMed ID: 32445926)
1. The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.
Stahler GJ; Mennis J
Drug Alcohol Depend; 2020 Jul; 212():108067. PubMed ID: 32445926
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US.
Stahler GJ; Mennis J; Baron DA
Drug Alcohol Depend; 2021 Sep; 226():108849. PubMed ID: 34198132
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.
Stahler GJ; Mennis J; Stein LAR; Belenko S; Rohsenow DJ; Grunwald HE; Brinkley-Rubinstein L; Martin RA
Drug Alcohol Depend; 2022 Jul; 236():109498. PubMed ID: 35605535
[TBL] [Abstract][Full Text] [Related]
4. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
[TBL] [Abstract][Full Text] [Related]
5. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states.
; Cole ES; Allen L; Austin A; Barnes A; Chang CH; Clark S; Crane D; Cunningham P; Fry CE; Gordon AJ; Hammerslag L; Idala D; Kennedy S; Kim JY; Krishnan S; Lanier P; Mahakalanda S; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Tang L; Zivin K; Donohue JM
Drug Alcohol Depend; 2022 Dec; 241():109670. PubMed ID: 36332591
[TBL] [Abstract][Full Text] [Related]
6. Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.
Walley AY; Lodi S; Li Y; Bernson D; Babakhanlou-Chase H; Land T; Larochelle MR
Addiction; 2020 Aug; 115(8):1496-1508. PubMed ID: 32096908
[TBL] [Abstract][Full Text] [Related]
7. Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.
Viera A; Bromberg DJ; Whittaker S; Refsland BM; Stanojlović M; Nyhan K; Altice FL
Epidemiol Rev; 2020 Jan; 42(1):41-56. PubMed ID: 32239206
[TBL] [Abstract][Full Text] [Related]
8. The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder.
Friesen EL; Kurdyak P
Drug Alcohol Depend; 2020 Nov; 216():108244. PubMed ID: 32861134
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
Curran L; Manuel J
Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
[TBL] [Abstract][Full Text] [Related]
10. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.
Askari MS; Martins SS; Mauro PM
J Subst Abuse Treat; 2020 Jul; 114():108028. PubMed ID: 32527510
[TBL] [Abstract][Full Text] [Related]
11. Predictors of availability of long-acting medication for opioid use disorder.
Shover CL; Humphreys K
Drug Alcohol Depend; 2019 Nov; 204():107586. PubMed ID: 31593871
[TBL] [Abstract][Full Text] [Related]
12. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
Klein AA; Seppala MD
J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
[TBL] [Abstract][Full Text] [Related]
13. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
[TBL] [Abstract][Full Text] [Related]
14. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
Han BH; Doran KM; Krawczyk N
J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
[TBL] [Abstract][Full Text] [Related]
15. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
[TBL] [Abstract][Full Text] [Related]
16. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
[TBL] [Abstract][Full Text] [Related]
17. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis.
Solomon KT; Bandara S; Reynolds IS; Krawczyk N; Saloner B; Stuart E; Connolly E
J Subst Abuse Treat; 2022 Jan; 132():108424. PubMed ID: 34144299
[TBL] [Abstract][Full Text] [Related]
18. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
[No Abstract] [Full Text] [Related]
19. Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: An analysis of the 2019 TEDS.
Welsh JW; Sitar SI; Hunter BD; Godley MD; Dennis ML
Drug Alcohol Depend; 2023 May; 246():109850. PubMed ID: 36989708
[TBL] [Abstract][Full Text] [Related]
20. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.
Krawczyk N; Williams AR; Saloner B; Cerdá M
J Subst Abuse Treat; 2021 Jul; 126():108329. PubMed ID: 34116820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
